Journal of the Korean Medical Association (대한의사협회지)

Korean Medical Association (대한의사협회)
권호 표지
DOI QR코드

DOI QR Code

Evidence-based management for osteoporosis

골다공증 관리와 과학적 근거

  • Lee, Kwan (Department of Preventive Medicine, Dongguk University College of Medicine)
  • 이관 (동국대학교 의과대학 예방의학교실)
  • Published : 2011.03.10
⟨ Previous Next ⟩

Abstract

Osteoporosis is the most common bone disease in humans, and it has caused major public health problems. Though osteoporosis affects all ages, its prevalence will increase as the population ages worldwide. In recent surveys of the Korean population, the prevalence of osteoporosis was 32.6% in women aged 50 years and above. Osteoporosis can be prevented, diagnosed easily, and treated before any fracture occurs. The active involvement of medical personnel and patients is needed. The prevention and management of osteoporosis are similar to other lifestyle-related diseases. Adequate intake of calcium and vitamin D, regular weight-bearing exercise, fall prevention, and avoidance of tobacco use and excessive alcohol intake are recommended for the general population. Bone mineral density testing and drug treatment must be considered to manage the risk factors of high risk groups. In this study, we review Korean and international research trends, and attempt to present an evidence-based strategy for the management of osteoporosis.

Keywords

References

  1. Korea National Statistical Office. Population projections for Korea 2001-2050: based on the 2005 population census. Daejeon: Korea National Statistical Office; 2006.
  2. Min YK. Clinician's guide to prevention and treatment of osteoporosis. Korean J Bone Metab 2008;15:99-107.
  3. Dell R, Greene D. Is osteoporosis disease management cost effective? Curr Osteoporos Rep 2010;8:49-55. https://doi.org/10.1007/s11914-010-0009-0
  4. WHO fracture risk assessment tool [Internet]. World Health Organization Collaborating Centre for Metabolic Bone Diseases; 2010 [cited 2010 Feb 10]. Available from: http://www.shef.ac.uk/FRAX.
  5. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington, D.C.: National Osteoporosis Foundation; 2010.
  6. The Korean Society of Bone Metabolism, Committee for Practice Guidelines. Physician's guide for diagnosis and treatment of osteoporosis. Seoul: The Korean Society of Bone Metabolism; 2010.
  7. World Health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: technical report series. No. 843. Geneva: World Health Organisation; 1994.
  8. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-795. https://doi.org/10.1001/jama.285.6.785
  9. Kanis JA, Gluer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 2000;11:192-202. https://doi.org/10.1007/s001980050281
  10. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 2006;194(2 Suppl):S3-S11. https://doi.org/10.1016/j.ajog.2005.08.047
  11. Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA 2009;302:1573-1579. https://doi.org/10.1001/jama.2009.1462
  12. Looker AC, Melton LJ 3rd, Harris TB, Borrud LG, Shepherd JA. Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. J Bone Miner Res 2010;25:64-71. https://doi.org/10.1359/jbmr.090706
  13. Lim S, Koo BK, Lee EJ, Park JH, Kim MH, Shin KH, Ha YC, Cho NH, Shin CS. Incidence of hip fractures in Korea. J Bone Miner Metab 2008;26:400-405. https://doi.org/10.1007/s00774-007-0835-z
  14. Ministry for Health, Welfare and Family Affairs; Korea Centers for Disease Control and Prevention. The 4th Korea National Health and Nutrition Examination Survey. Cheongwon: Korea Centers for Disease Control and Prevention; 2009.
  15. Choi JY, Park SK, Cho SI, Kang D, Shin A, Shin CS, Han S. Prevalence and risk factors of osteoporosis and osteopenia in korean women: cross-sectional study. J Korean Soc Menopause 2008;14:35-49.
  16. Kim CH, Kim YI, Choi CS, Park JY, Kim GS, Lee MS, Lee SI. Prevalence of osteoporosis in Jung-Up district, Korea. Korean J Bone Metab 1997;4:66-71.
  17. Shin MH, Shin HY, Jung EK, Rhee JA. Prevalence of osteoporosis and related factors in the elderly women over 60 years of age. J Korean Geriatr Soc 2002;6:130-139.
  18. Kim YI, Park JH, Lee JS, Kim JW, Yang SO, Jeon DJ, Kim MC, Jeong TH, Lee YG, Rhee BD. Prevalence and risk factors of the osteoporosis of perimenopausal women in the community population. Korean J Med 2002;62:11-24.
  19. Lee WS, Park HM, Bae DH. Prevalence of osteoporosis in korean women. J Korean Soc Menopause 2003;9:340-346.
  20. Cho NH, Shin C, Park C, Kimm KC. Geographic difference in the prevalence of osteoporosis in Korea. J Korean Soc Osteoporos 2005;3:98-109.
  21. Jung SE, Yoon YS, Kim T, Kim HJ, Lee NW, Lee KW, Kim SH. Estimated prevalence of osteoporosis in Ansan, Korea. J Korean Soc Osteoporos 2006;4:41-48.
  22. Jin LH, Kim KS, Kang MG, Ryu SY, Lee CG, Park JK, Koh SB, Eom AY. The prevalence of osteoporosis and its related factors among some rural women. J Korean Soc Matern Child Health 2007;11:64-77. https://doi.org/10.21896/jksmch.2007.11.1.64
  23. Jeon GH, Kim SR, Kim SH, Chae HD, Kim CH, Kang BM. Prevalence of osteoporosis and osteopenia in women in Kangwon province: geographical comparison study. Korean J Bone Metab 2008;15:135-141.
  24. Khosla S, Riggs BL. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol Metab Clin North Am 2005;34:1015-1030. https://doi.org/10.1016/j.ecl.2005.07.009
  25. Gennari L, Bilezikian JP. Osteoporosis in men. Endocrinol Metab Clin North Am 2007;36:399-419. https://doi.org/10.1016/j.ecl.2007.03.008
  26. Singer AJ, Boonen S. Osteoporosis management: translating research into optimal fracture protection II. Curr Med Res Opin 2008;24:1789-1796. https://doi.org/10.1185/03007990802115887
  27. Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Po sition Development Conference. J Clin Densitom 2008;11:75-91. https://doi.org/10.1016/j.jocd.2007.12.007
  28. Lee KH. Diagnosis of osteoporosis. J Korean Hip Soc 2007;19:260-265.
  29. Yang SO, Kim S, Juhng SK. Imaging diagnosis of osteoporotic fracture. J Korean Med Assoc 2010;53:67-75. https://doi.org/10.5124/jkma.2010.53.1.67
  30. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254-1259. https://doi.org/10.1136/bmj.312.7041.1254
  31. Lewiecki EM, Watts NB, McClung MR, Petak SM, Bachrach LK, Shepherd JA, Downs RW Jr. Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab 2004;89:3651-3655. https://doi.org/10.1210/jc.2004-0124
  32. Lydick E, Cook K, Turpin J, Melton M, Stine R, Byrnes C. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care 1998;4:37-48.
  33. Cadarette SM, Jaglal SB, Kreiger N, McIsaac WJ, Darlington GA, Tu JV. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ 2000;162:1289-1294.
  34. Weinstein L, Ullery B. Identification of at-risk women for osteoporosis screening. Am J Obstet Gynecol 2000;183:547-549. https://doi.org/10.1067/mob.2000.106594
  35. Koh LK, Sedrine WB, Torralba TP, Kung A, Fujiwara S, Chan SP, Huang QR, Rajatanavin R, Tsai KS, Park HM, Reginster JY; Osteoporosis Self-Assessment Tool for Asians (OSTA) Research Group. A simple tool to identify asian women at increased risk of osteoporosis. Osteoporos Int 2001;12:699-705. https://doi.org/10.1007/s001980170070
  36. Song TJ, Choi H, Lee S, Yeon MJ, Ko JK, Lee CM, Cho YK, Kim BR. Performance of risk indeces for prediction of osteoporosis in post- and perimenopausal women. Korean J Obstet Gynecol 2005;48:2627-2634.
  37. Cadarette SM, Jaglal SB, Murray TM, McIsaac WJ, Joseph L, Brown JP; Canadian Multicentre Osteoporosis Study. Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA 2001;286:57-63. https://doi.org/10.1001/jama.286.1.57
  38. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002;359:1929-1936. https://doi.org/10.1016/S0140-6736(02)08761-5
  39. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-397 https://doi.org/10.1007/s00198-007-0543-5
  40. Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E. FRAX and its applications to clinical practice. Bone 2009;44:734-743. https://doi.org/10.1016/j.bone.2009.01.373
  41. Kleerekoper M, Gold DT. Osteoporosis prevention and management: an evidence-based review. Clin Obstet Gynecol 2008;51:556-563. https://doi.org/10.1097/GRF.0b013e3181809ae0
  42. Mayes SL. Review of postmenopausal osteoporosis pharmacotherapy. Nutr Clin Pract 2007;22:276-285. https://doi.org/10.1177/0115426507022003276
  43. Brixen K, Kassem M, Abrahamsen B. Prevention and treatment of osteoporosis in women: an update. Obstet Gynaecol Reprod Med 2009;19:157-163. https://doi.org/10.1016/j.ogrm.2009.03.001
  44. The Korean Nutrition Society. Dietary reference intakes for Koreans. Seoul: The Korean Nutrition Society; 2010.
  45. Holick MF. McCollum Award Lecture, 1994: vitamin D-new horizons for the 21st century. Am J Clin Nutr 1994;60:619-630. https://doi.org/10.1093/ajcn/60.4.619
  46. Lee HH. A role of vitamin D in postmenopausal women. J Korean Soc Menopause 2008;14:109-114.
  47. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713-716. https://doi.org/10.1007/s00198-005-1867-7
  48. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999;282:637-645. https://doi.org/10.1001/jama.282.7.637
  49. Tosteson AN, Burge RT, Marshall DA, Lindsay R. Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. Am J Manag Care 2008;14:605-615.
  50. Park HM. Current use of drugs for osteoporosis in Korea. Korean J Obstet Gynecol 2010;53:152-159. https://doi.org/10.5468/kjog.2010.53.2.152
  51. Aloia JF, Cohn SH, Ostuni JA, Cane R, Ellis K. Prevention of involutional bone loss by exercise. Ann Intern Med 1978;89:356-358. https://doi.org/10.7326/0003-4819-89-3-356
  52. Grisso JA, Kelsey JL, Strom BL, Chiu GY, Maislin G, O'Brien LA, Hoffman S, Kaplan F. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med 1991;324:1326-1331. https://doi.org/10.1056/NEJM199105093241905

Cited by

  1. 폐경 후 여성 골다공증과 낙상의 실태 및 골절 위험 예측요인 vol.18, pp.4, 2011, https://doi.org/10.4069/kjwhn.2012.18.4.237
  2. 골다공증 유병률, 인지율, 치료율 및 영향요인의 성별 비교: 국민건강영양조사 자료(2008~2011년) 활용 vol.45, pp.2, 2011, https://doi.org/10.4040/jkan.2015.45.2.293
  3. 25-Hydroxyvitamin D is Associated with Osteosarcopenia: the 2009-2011 Korea National Health and Nutrition Examination Survey vol.45, pp.2, 2020, https://doi.org/10.21032/jhis.2020.45.2.139
  4. 폐경 후 여성의 골다공증 유병 관련 요인 vol.28, pp.2, 2011, https://doi.org/10.5953/jmjh.2021.28.2.91